We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

35 hedge funds and large institutions have $147M invested in Loxo Oncology, Inc in 2014 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
+$44.8M
2
O
OrbiMed
New York
+$28.2M
3
DM
Deerfield Management
New York
+$20.6M
4
BI
BVF Inc
California
+$15.5M
5
RIM
RS Investment Management
California
+$7.78M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$94K +$92.4K +7,125 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$88K +$86.9K +6,700 New
Morgan Stanley
28
Morgan Stanley
New York
$74K +$73.1K +5,631 New
TCIM
29
TIAA CREF Investment Management
New York
$64K +$63.3K +4,879 New
TA
30
Teachers Advisors
New York
$44K +$43.8K +3,373 New
SO
31
STRS Ohio
Ohio
$16K +$15.6K +1,200 New
BA
32
BlackRock Advisors
Delaware
$16K +$15.8K +1,214 New
MAA
33
Managed Account Advisors
New Jersey
$9K +$8.74K +674 New
Citigroup
34
Citigroup
New York
$2K +$1.65K +127 New
U
35
UBS
Switzerland
$2K +$2.01K +155 New
1
2

LOXO Hedge Fund Activity: Q3 2014 in Review

35 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2014, worth a combined $147M.

Buyers outnumbered sellers: 35 funds opened new LOXO positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Aisling Capital, opening a new position worth an estimated $44.8M.

  • 35 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $147M of Loxo Oncology, Inc stock for Q3 2014.
  • 35 funds opened new Loxo Oncology, Inc positions in Q3 2014 and 0 closed out, a net change of +35 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2014 was Aisling Capital, an estimated $44.8M added.

Based on aggregated 13F filings for Q3 2014.